Avalo Therapeutics, Inc. (AVTX) — Stock Score Summary

Avalo Therapeutics, Inc. (AVTX) has a MoatMap StockRank of 14/100 based on Quality (29/100), Value (33/100), and Momentum (36/100) factor scores. The current signal is STRONG SELL. Avalo Therapeutics is a micro-cap clinical-stage biotech company. It lacks commercialized products, has negative cash flows, and is highly speculative, failing all core quality and margin of safety criteria.

Avalo Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases and cancers. The company leverages a pipeline of innovative drug candidates, often in-licensed, to address significant unmet medical needs in specialized patient populations. Its strategy involves targeted development and potential partnerships to bring novel treatments to market.

Key Financial Metrics

Price$12.90
Market Cap$848M
P/E (Forward)-4.74
Price/Book4.91
Return on Equity-88.8%
Return on Invested Capital-70.4%
Debt/Equity0.48
Gross Margin0.0%
Operating Margin-134164.4%
Free Cash Flow$-23M

Avalo Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Avalo Therapeutics, Inc.’s (AVTX) StockRank?
MoatMap’s StockRank for Avalo Therapeutics, Inc. (AVTX) is 14/100, with a Strong Sell signal. It is a composite of Quality (29), Value (33), and Momentum (36) factor ranks across MoatMap’s 19,000+ stock universe.
Does Avalo Therapeutics, Inc. have an economic moat?
Avalo Therapeutics, Inc. (AVTX) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Avalo Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Avalo Therapeutics, Inc. (AVTX) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Avalo Therapeutics, Inc. in?
Avalo Therapeutics, Inc. (AVTX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksAVTX deep dive reportAI ChampionsHow we score stocksSense-check another stock